PFIZER REPORTS THIRD-QUARTER 2019 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pfizer (PFE) Tops Q3 EPS by 13c, Raises FY Guidance
October 29, 2019 6:46 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.26 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.94-$3.00, versus the consensus of $2.82. Pfizer sees... More
